Bagby RM, Parker JD, Taylor GJ The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994 Jan;38(1):23-32. doi: 10.1016/0022-3999(94)90005-1.
Cerutti R, Spensieri V, Valastro C, Presaghi F, Canitano R, Guidetti V A comprehensive approach to understand somatic symptoms and their impact on emotional and psychosocial functioning in children. PLoS One. 2017 Feb 8;12(2):e0171867. doi: 10.1371/journal.pone.0171867. eCollection 2017.
Coddington RD The significance of life events as etiologic factors in the diseases of children. II. A study of a normal population. J Psychosom Res. 1972 Jun;16(3):205-13. doi: 10.1016/0022-3999(72)90045-1. No abstract available.
Ha C, Sharp C, Ensink K, Fonagy P, Cirino P The measurement of reflective function in adolescents with and without borderline traits. J Adolesc. 2013 Dec;36(6):1215-23. doi: 10.1016/j.adolescence.2013.09.008. Epub 2013 Oct 25.
Janssens KA, Oldehinkel AJ, Rosmalen JG Parental overprotection predicts the development of functional somatic symptoms in young adolescents. J Pediatr. 2009 Jun;154(6):918-23.e1. doi: 10.1016/j.jpeds.2008.12.023. Epub 2009 Feb 1.
Janssens KA, Rosmalen JG, Ormel J, van Oort FV, Oldehinkel AJ Anxiety and depression are risk factors rather than consequences of functional somatic symptoms in a general population of adolescents: the TRAILS study. J Child Psychol Psychiatry. 2010 Mar;51(3):304-12. doi: 10.1111/j.1469-7610.2009.02174.x. Epub 2009 Sep 28.
Luyten P, Mayes LC, Nijssens L, Fonagy P The parental reflective functioning questionnaire: Development and preliminary validation. PLoS One. 2017 May 4;12(5):e0176218. doi: 10.1371/journal.pone.0176218. eCollection 2017.
Moreno MA Functional abdominal pain in children and adolescents. JAMA Pediatr. 2013 Feb;167(2):204. doi: 10.1001/jamapediatrics.2013.1665. No abstract available.
Schulte IE, Petermann F Somatoform disorders: 30 years of debate about criteria! What about children and adolescents? J Psychosom Res. 2011 Mar;70(3):218-28. doi: 10.1016/j.jpsychores.2010.08.005. Epub 2010 Nov 4.
Taylor EM, Boyer K, Campbell FA Pain in hospitalized children: a prospective cross-sectional survey of pain prevalence, intensity, assessment and management in a Canadian pediatric teaching hospital. Pain Res Manag. 2008 Jan-Feb;13(1):25-32. doi: 10.1155/2008/478102.
Taylor GJ, Parker JD, Bagby RM, Acklin MW Alexithymia and somatic complaints in psychiatric out-patients. J Psychosom Res. 1992 Jul;36(5):417-24. doi: 10.1016/0022-3999(92)90002-j.
Troisi A, D'Argenio A, Peracchio F, Petti P Insecure attachment and alexithymia in young men with mood symptoms. J Nerv Ment Dis. 2001 May;189(5):311-6. doi: 10.1097/00005053-200105000-00007.
van der Veek SM, Derkx HH, de Haan E, Benninga MA, Boer F Emotion awareness and coping in children with functional abdominal pain: a controlled study. Soc Sci Med. 2012 Jan;74(2):112-9. doi: 10.1016/j.socscimed.2011.10.023. Epub 2011 Nov 27.
Wearden AJ, Lamberton N, Crook N, Walsh V Adult attachment, alexithymia, and symptom reporting: an extension to the four category model of attachment. J Psychosom Res. 2005 Mar;58(3):279-88. doi: 10.1016/j.jpsychores.2004.09.010.
Somatic Symptoms, Alexithymia and Styles of Attachment: a Cross-sectional Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.